Pay in 4 interest-free payments of $7.14 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
There are also several distinctions
Available at: (Accessed: 27th August 2015)
Ultimately, by early November 2025 Metsera accepted Pfizers sweetened offer: $86.25 per share ($10.0 billion total) comprising $65.60 cash and up to $20.65 in contingent value rights (CVRs) ( [6] ) ( [7] )
CasalechiMPiontiniANicolosiABergomasFNapolitanoFTuroloSet al
On the data side, the Lau phase 2 obesity trial showed Cagrilintide monotherapy producing dose-related weight loss, reaching close to 10.8 percent at the top dose over roughly 26 weeks, against about 3 percent on placebo
US$ 21.84
US$ 29.38
US$ 25.80
US$ 24.29
US$ 21.21
